MOST POSITIVE B-CELL CROSSMATCHES ARE NOT CAUSED BY ANTI-HLA-DR ANTIBODIES

被引:25
|
作者
DAPICE, AJF [1 ]
TAIT, BD [1 ]
机构
[1] ROYAL MELBOURNE HOSP,TISSUE TYPING LAB,MELBOURNE,VIC 3050,AUSTRALIA
关键词
D O I
10.1097/00007890-198011000-00015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:382 / 383
页数:2
相关论文
共 50 条
  • [41] ANTI-HLA-DR AUTOREACTIVE T-CELL IN NORMAL AND BONE-MARROW GRAFT PATIENTS
    TILKIN, AF
    VINCI, G
    KAYIBANDA, M
    LEVY, JP
    IMMUNOBIOLOGY, 1986, 173 (2-5) : 376 - 376
  • [42] A PATIENT WITH REPEATEDLY POSITIVE ALLOGENEIC CROSSMATCHES DUE TO NON-HLA ANTIBODIES
    Chou-Wu, E.
    Youngs, D.
    Gimferrer, I.
    Weiss, A.
    HUMAN IMMUNOLOGY, 2021, 82 : 70 - 70
  • [43] Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways
    Stein, Rhona
    Gupta, Pankaj
    Chen, Xiaochuan
    Cardillo, Thomas M.
    Furman, Richard R.
    Chen, Susan
    Chang, Chien-Hsing
    Goldenberg, David M.
    BLOOD, 2010, 115 (25) : 5180 - 5190
  • [45] Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1
    Bestman-Smith, J
    Gourde, P
    Désormeaux, A
    Tremblay, MJ
    Bergeron, MG
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2000, 1468 (1-2): : 161 - 174
  • [46] Therapy of B-Cell Malignancies by Anti-HLA-DR Humanized Monoclonal Antibody, IMMU-114, Is Mediated through Hyperactivation of ERK and JNK MAP Kinase Signaling Pathways
    Gupta, Pankaj
    Stein, Rhona
    Cardillo, Thomas M.
    Furman, Richard R.
    Chen, Susan
    Chang, Chien-Hsing
    Goldenberg, David M.
    BLOOD, 2009, 114 (22) : 1439 - 1439
  • [47] Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab' fragments
    Dufresne, I
    Désormeaux, A
    Bestman-Smith, J
    Gourde, P
    Tremblay, MJ
    Bergeron, MG
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1421 (02): : 284 - 294
  • [48] Humanization and characterization of the anti-HLA-DR antibody 1D10
    Kostelny, SA
    Link, BK
    Tso, JY
    Vasquez, M
    Jorgensen, BH
    Wang, H
    Hall, WC
    Weiner, GJ
    INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (04) : 556 - 565
  • [49] EFFECTS OF AN ANTI-HLA-DR IMMUNOTOXIN ON LEUKEMIA-CELLS AND HEMATOPOIETIC PROGENITORS
    DEMUR, C
    DEROCQ, JM
    PONCELET, P
    CHIRON, M
    ROUBINET, F
    JAFFREZOU, JP
    BORDIER, C
    LAURENT, G
    LEUKEMIA RESEARCH, 1989, 13 (12) : 1047 - 1054
  • [50] Positive Flow Cytometery Crossmatches and HLA Antibodies May Not Be Contraindications to Heart Transplantation
    Kerman, R. H.
    Radovancevic, R.
    Allison, P. A.
    McKissick, E.
    Bogaev, R.
    Bracey, A. W.
    Allison, S.
    Gregoric, L.
    Frazier, O. H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S151 - S151